Filing Details

Accession Number:
0000711377-16-000075
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-08-02 18:50:42
Reporting Period:
2016-07-29
Filing Date:
2016-08-02
Accepted Time:
2016-08-02 18:50:42
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1189021 Edward Bradley Vice President No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-07-29 4,200 $23.07 126,730 No 4 M Direct
Common Stock Disposition 2016-07-29 4,200 $55.45 122,530 No 4 S Direct
Common Stock Acquisiton 2016-08-01 15,996 $23.07 138,526 No 4 M Direct
Common Stock Disposition 2016-08-01 15,996 $55.65 122,530 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Common Stock ( Right to Buy) Disposition 2016-07-29 4,200 $0.00 4,200 $23.07
Common Stock Common Stock (Right to buy) Disposition 2016-08-01 15,996 $0.00 15,996 $23.07
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
133,052 2016-09-29 No 4 M Direct
117,056 2016-09-29 No 4 M Direct
Footnotes
  1. Options were granted on 9/29/2011, have five year lives, and vest in equal 20% installments on each anniversary date of the grant